Figueroa-Valverde, L. et al. 2025. Theoretical interaction of muscarinic receptor antagonist with vascular endothelial growth factor receptors (VEGF-R1, R2 and R3) as a therapeutic alternative to treat cancer. Brazilian Journal of Science. 4, 5 (Apr. 2025), 1–14. DOI:https://doi.org/10.14295/bjs.v4i5.734.